132 related articles for article (PubMed ID: 1383872)
1. Amyloidoma of the CNS. II. Immunohistochemical and biochemical study.
Vidal RG; Ghiso J; Gallo G; Cohen M; Gambetti PL; Frangione B
Neurology; 1992 Oct; 42(10):2024-8. PubMed ID: 1383872
[TBL] [Abstract][Full Text] [Related]
2. Brain-restricted amyloidoma of immunoglobulin lambda-light chain origin clinically resembling multiple sclerosis.
Linke RP; Gerhard L; Lottspeich F
Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1201-9. PubMed ID: 1292505
[TBL] [Abstract][Full Text] [Related]
3. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis.
Zaky ZS; Liepnieks JJ; Rex DK; Cummings OW; Benson MD
Amyloid; 2007 Dec; 14(4):299-304. PubMed ID: 17968691
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
[TBL] [Abstract][Full Text] [Related]
5. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
Kuçi H; Ebert MP; Röcken C
Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
7. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data.
Kaplan B; Martin BM; Livneh A; Pras M; Gallo GR
Am J Clin Pathol; 2004 Jun; 121(6):794-800. PubMed ID: 15198349
[TBL] [Abstract][Full Text] [Related]
8. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain.
Eriksson L; Sletten K; Benson L; Westermark P
Scand J Immunol; 1993 Jun; 37(6):623-6. PubMed ID: 8316759
[TBL] [Abstract][Full Text] [Related]
9. Novel isolated cerebral ALlambda amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy.
Schröder R; Deckert M; Linke RP
J Neuropathol Exp Neurol; 2009 Mar; 68(3):286-99. PubMed ID: 19225408
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
11. Localized amyloidosis of the larynx: evidence for light chain composition.
Berg AM; Troxler RF; Grillone G; Kasznica J; Kane K; Cohen AS; Skinner M
Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):884-9. PubMed ID: 8239352
[TBL] [Abstract][Full Text] [Related]
12. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
13. Partial amino acid sequence of an amyloid fibril protein from unusual cutaneous cystic lesions in myeloma-associated amyloidosis.
Akiyama T; Seishima M; Nojiri M; Satoh M; Ichiki Y; Kitajima Y
Eur J Dermatol; 1999 Dec; 9(8):624-8. PubMed ID: 10586130
[TBL] [Abstract][Full Text] [Related]
14. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein.
Haltia M; Prelli F; Ghiso J; Kiuru S; Somer H; Palo J; Frangione B
Biochem Biophys Res Commun; 1990 Mar; 167(3):927-32. PubMed ID: 2157434
[TBL] [Abstract][Full Text] [Related]
15. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils.
Kitajima Y; Seno J; Aoki S; Tada S; Yaoita H
Arch Dermatol; 1986 Dec; 122(12):1425-30. PubMed ID: 3789778
[TBL] [Abstract][Full Text] [Related]
16. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
17. Organ-specific (localized) synthesis of Ig light chain amyloid.
Hamidi Asl K; Liepnieks JJ; Nakamura M; Benson MD
J Immunol; 1999 May; 162(9):5556-60. PubMed ID: 10228037
[TBL] [Abstract][Full Text] [Related]
18. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
20. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
Westermark GT; Sletten K; Grubb A; Westermark P
Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
